---

•	Neurology Center Home
•	Diseases A-Z

More Features

•	Printer-friendly version

Supranuclear ophthalmoplegia

Definition

Supranuclear ophthalmoplegia is a condition that affects the movement of the eyes.

Alternative Names

Progressive supranuclear palsy - supranuclear ophthalmoplegia; Encephalitis - supranuclear ophthalmoplegia; Olivopontocerebellar atrophy - supranuclear ophthalmoplegia; Amyotrophic lateral sclerosis - supranuclear ophthalmoplegia; Whipple disease - supranuclear ophthalmoplegia; Dementia - supranuclear ophthalmoplegia

Causes

This disorder occurs because the brain is sending and receiving faulty information through the nerves that control eye movement. The nerves themselves are healthy.

People who have this problem often have progressive supranuclear palsy (PSP). This is a disorder that affects the way the brain controls movement, including eye movement.

Other disorders that have been associated with this condition include:

• Inflammation of the brain (encephalitis)
• Disease that causes areas deep in the brain, just above the spinal cord, to shrink (olivopontocerebellar atrophy)
• Disease of the nerve cells in the brain and spinal cord that control voluntary muscle movement (for example, amyotrophic lateral sclerosis)
• Condition that also causes malabsorption disorder of the small intestine as well as other symptoms (Whipple disease)

Symptoms

People with supranuclear ophthalmoplegia are unable to move their eyes at will in all directions, especially looking upward.

Depending on what condition may be causing the supranuclear ophthalmoplegia, associated symptoms may include:

• Mild dementia
• Stiff and uncoordinated movements like those of Parkinson disease
• Symptoms of disorders associated with supranuclear ophthalmoplegia

Exams and Tests

Your health care provider will perform a physical exam and ask about the symptoms, focusing on the eyes and nervous system.

Tests will be done to check for diseases linked with supranuclear ophthalmoplegia. Magnetic resonance imaging (MRI) might show shrinking of the brainstem.

Treatment

Treatment depends on the cause and symptoms of the supranuclear ophthalmoplegia.

Outlook (Prognosis)

Outlook depends on the cause of the supranuclear ophthalmoplegia.

References

Lavin PJM, Donahue SP, Longmuir RA. Disorders of supranuclear control of ocular motility. In: Yanoff M, Duker JS, eds. Ophthalmology. 6th ed. Philadelphia, PA: Elsevier; 2023:chap 9.14.

Lin CR. Progressive supranuclear palsy. In: Ferri FF, ed. Ferri's Clinical Advisor 2025. Philadelphia, PA: Elsevier; 2025:chap 918.e4-918e6.

Ling H. Clinical approach to progressive supranuclear palsy. J Mov Disord. 2016;9(1):3-13. PMID: 26828211 www.pubmed.ncbi.nlm.nih.gov/26828211/.

Rucker JC, Lavin PJM. Neuro-ophthalmology: ocular motor system. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 18.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language.

© 1997- A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

All content on this site including text, images, graphics, audio, video, data, metadata, and compilations is protected by copyright and other intellectual property laws. You may view the content for personal, noncommercial use. Any other use requires prior written consent from Ebix. You may not copy, reproduce, distribute, transmit, display, publish, reverse-engineer, adapt, modify, store beyond ordinary browser caching, index, mine, scrape, or create derivative works from this content. You may not use automated tools to access or extract content, including to create embeddings, vectors, datasets, or indexes for retrieval systems. Use of any content for training, fine-tuning, calibrating, testing, evaluating, or improving AI systems of any kind is prohibited without express written consent. This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs. Any unauthorized use of the content including AI-related use is a violation of our rights and may result in legal action, damages, and statutory penalties to the fullest extent permitted by law. Ebix reserves the right to enforce its rights through legal, technological, and contractual measures.

© 1997- All rights reserved.